Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 6/20 | 0.42 |
| ▸ | CASP3 | P42574 | 4/20 | 0.39 |
| ▸ | CASP7 | P55210 | 2/20 | 0.39 |
| ▸ | CASP2 | P42575 | 1/20 | 0.39 |
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | RGS12 | O14924 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL626418 | 0.98 | GSK3B (0.46) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| Acrylic Acid SCHEMBL11605192 | 0.89 | KDM4E (0.44) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL19245114 | 0.83 | GSK3B (0.39) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL12430646 | 0.83 | GSK3B (0.39) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL31229225 | 0.81 | GSK3B (0.48) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL1627401 | 0.81 | GSK3B (0.48) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL28735098 | 0.81 | GSK3B (0.41) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL579203 | 0.79 | GSK3B (0.46) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL8577337 | 0.76 | KDM4E (0.45) | GSK3BKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL16754925 | 0.75 | GSK3B (0.62) | GSK3BKDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2371398-B1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO LTD (JP) | 2013-05-15 | — | — | EP | claimed |
| US-20240207482-A1 | SURFACE TREATMENT METHODS FOR CEMENTLESS IMPLANTABLE MEDICAL DEVICES | DURAHIP, LLC | 2024-06-27 | — | — | US | disclosed |
| EP-3586882-B1 | ANTIBACTERIAL BIOLOGICAL IMPLANT | PROSTEC CO LTD (JP) | 2023-02-22 | — | — | EP | disclosed |
| EP-3981444-A1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | Biomet Manufacturing, LLC (US) | 2022-04-13 | — | — | EP | disclosed |
| EP-3586883-B1 | METHOD FOR PRODUCING ANTIBACTERIAL BIOLOGICAL IMPLANT | PROSTEC CO LTD (JP) | 2021-11-17 | — | — | EP | disclosed |
| US-20210186703-A1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | BIOMET MFG LLC (US) | 2021-06-24 | — | — | US | disclosed |
| US-10980914-B2 | Antibacterial biological implant | PROSTEC CO., LTD. (JP) | 2021-04-20 | — | — | US | disclosed |
| EP-3391915-B1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | BIOMET MFG LLC (US) | 2021-04-14 | — | — | EP | disclosed |
| US-10940234-B2 | Method for producing antibacterial biological implant | PROSTEC CO., LTD. (JP) | 2021-03-09 | — | — | US | disclosed |
| US-10893944-B2 | Methods of modifying the porous surface of implants | BIOMET MANUFACTURING, LLC (US) | 2021-01-19 | — | — | US | disclosed |
| US-10668187-B2 | Medical supplies and method of producing the same | PROSTEC CO., LTD. (JP) | 2020-06-02 | — | — | US | disclosed |
| US-20200030487-A1 | METHOD FOR PRODUCING ANTIBACTERIAL BIOLOGICAL IMPLANT | PROSTEC CO., LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| EP-3391915-A2 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | Biomet Manufacturing, LLC (US) | 2018-10-24 | — | — | EP | disclosed |
| US-20180280143-A1 | METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS | BIOMET MANUFACTURING, LLC | 2018-10-04 | — | — | US | disclosed |
| US-20180243483-A1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO LTD (JP) | 2018-08-30 | — | — | US | disclosed |
| US-9889231-B2 | Medical supplies and method of producing the same | PROSTEC CO., LTD. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20130240365-A1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO., LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| EP-2371398-B1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO LTD (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-20110313539-A1 | MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME | PROSTEC CO., LTD. (JP) | 2011-12-22 | — | — | US | disclosed |
| EP-2371398-A1 | MEDICAL PART AND MANUFACTURING METHOD THEREFOR | Prostec Co., Ltd. (JP) | 2011-10-05 | — | — | EP | disclosed |